This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Muni Bhaskar Pallooru: Innovator in Pharmaceutical Processes
Introduction
Muni Bhaskar Pallooru is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of Ceritinib, a drug used in cancer treatment. His innovative approaches have led to advancements in the efficiency and cost-effectiveness of drug production.
Latest Patents
Muni Bhaskar Pallooru holds a patent for a modified process for the preparation of Ceritinib and its amorphous form. This invention is related to an improved method that achieves high yield and high purity in the production of Ceritinib. The process is not only cost-effective but also feasible for large-scale production. Additionally, his patent includes a stable amorphous form of Ceritinib and a process for preparing Crystalline form A of Ceritinib.
Career Highlights
Muni Bhaskar Pallooru is currently associated with Natco Pharma Limited, where he applies his expertise in pharmaceutical innovations. His work has contributed to the company's reputation for developing effective and affordable medications. His dedication to improving drug formulation processes has made a significant impact in the pharmaceutical industry.
Collaborations
Muni has collaborated with several professionals in his field, including Durga Prasad Konakanchi and Subba Rao Pula. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical processes.
Conclusion
Muni Bhaskar Pallooru is a distinguished inventor whose work in the preparation of Ceritinib has paved the way for more efficient pharmaceutical production. His contributions are vital to the ongoing development of effective cancer treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
